Patents by Inventor Austin Herr

Austin Herr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING CANCER
    Publication number: 20180326088
    Abstract: The present invention provides compositions for targeting SAS1B positive cancer cells using immunotoxin technology and discloses that kidney and pancreatic cancer cells are SAS1B positive, but not normal kidney and pancreatic cells. The invention discloses that despite being expressed only in growing oocytes in females among normal tissues SAS1B is expressed in cancers of both men and women.
    Type: Application
    Filed: July 23, 2018
    Publication date: November 15, 2018
    Applicant: University of Virginia Patent Foundation
    Inventors: John C. Herr, Eusebio S. Piers, Austin Herr
  • COMPOSITIONS AND METHODS FOR TREATING CANCER
    Publication number: 20170298141
    Abstract: The present invention provides compositions for targeting SAS1B positive cancer cells using immunotoxin technology and discloses that kidney and pancreatic cancer cells are SAS1B positive, but not normal kidney and pancreatic cells. The invention discloses that despite being expressed only in growing oocytes in females among normal tissues SAS1B is expressed in cancers of both men and women.
    Type: Application
    Filed: April 28, 2017
    Publication date: October 19, 2017
    Applicant: University of Virginia Patent Foundation
    Inventors: John C. Herr, Eusebio S. Pires, Austin Herr
  • COMPOSITIONS AND METHODS FOR TREATING CANCER
    Publication number: 20150125445
    Abstract: The present invention provides compositions for targeting SAS1B positive cancer cells using immunotoxin technology and discloses that kidney and pancreatic cancer cells are SAS1B positive, but not normal kidney and pancreatic cells. The invention discloses that despite being expressed only in growing oocytes in females among normal tissues SAS1B is expressed in cancers of both men and women.
    Type: Application
    Filed: June 13, 2013
    Publication date: May 7, 2015
    Inventors: John C. Herr, Eusebio S. Pires, Austin Herr